Mitoguazone, CAS [[459-86-9]]

Catalog Number: TGM-T35617
Article Name: Mitoguazone, CAS [[459-86-9]]
Biozol Catalog Number: TGM-T35617
Supplier Catalog Number: T35617
Alternative Catalog Number: TGM-T35617-1MG,TGM-T35617-5MG,TGM-T35617-10MG,TGM-T35617-25MG,TGM-T35617-50MG,TGM-T35617-100MG,TGM-T35617-200MG
Manufacturer: TargetMol
Category: Biochemikalien
Alternative Names: MGBG , Methyl-GAG
Mitoguazone (Methyl-GAG) is a selective S-adenosyl-methionine decarboxylase inhibitor that penetrates the blood-brain barrier and disrupts polyamine biosynthesis. Mitoguazone is a synthetic polycarbonyl derivative with anti-tumor activity that inhibits the integration of HIV DNA into cellular DNA in monocytes and macrophages, inducing apoptosis. Mitoguazone can be used to prevent acute leukemia, Hodgkin lymphoma and non-Hodgkin lymphoma.
Molecular Weight: 184.2
Purity: 98.00%
CAS Number: [459-86-9]
Formula: C5H12N8
Target: Apoptosis|||HIV Protease
T35617